ArticleNPJ genomic medicine2026

Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.

Giampaolo Trivellin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.